Want to see GB:MVR2 full AI Analyst Report?
Marwyn Value Investors Ltd (MVR2) AI Stock Analysis
Marwyn Value Investors Ltd
(LSE:MVR2)
The company's rock-solid balance sheet and extremely low P/E ratio are the primary strengths, indicating a financially healthy and deeply undervalued company. However, the score is significantly weighed down by a very weak technical picture, with the stock in a clear downtrend and strong bearish momentum. Revenue volatility, typical for the industry, is a secondary risk.
Marwyn Value Investors Ltd (MVR2) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 56.53M
- Dividend Yield
- ―
- Average Volume (3M)
- 17.37K
- Price to Earnings (P/E)
- 3.9
- Beta (1Y)
- -0.03
- Revenue Growth
- -0.03%
- EPS Growth
- 106.45%
- Country
- UK
- Employees
- 11
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
Marwyn Value Investors Ltd Business Overview & Revenue Model
Company Description
Marwyn Value Investors Limited is dedicated to deploying capital into small and mid-sized companies, supporting their expansion through growth financing, management buyouts, strategic industry consolidation, and acquisition-driven growth plans. It al...
How the Company Makes Money
Marwyn Value Investors Ltd makes money primarily through investment returns generated by its portfolio. These returns typically include (i) capital appreciation (realised when investments are sold for more than their cost, and unrealised as market va...
Marwyn Value Investors Ltd Financial Statement Overview
Summary
Strong financial health with a 95/100 balance sheet, 85/100 income statement, and 75/100 cash flow. Revenue grew 55% with near-100% net margins, negligible debt, and a 26% ROE. Cash flow is stable but conversion is modest due to non-cash mark-to-market gains.
Income Statement
85Very PositiveBalance Sheet
95Very PositiveCash Flow
75Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -723.48K | 38.56M | 18.67M | 4.87M | 2.05M | 19.09M |
| Gross Profit | -723.48K | 38.55M | 18.67M | 4.87M | 5.03M | 19.09M |
| EBITDA | 23.86M | 38.55M | -18.68M | 4.87M | 2.05M | 19.09M |
| Net Income | 20.62M | 38.55M | 18.67M | 4.86M | 2.05M | 19.09M |
Balance Sheet | ||||||
| Total Assets | 142.80M | 148.56M | 115.03M | 101.38M | 102.42M | 105.40M |
| Cash, Cash Equivalents and Short-Term Investments | 144.97K | 143.50K | 140.04K | 133.99K | 129.15K | 128.55K |
| Total Debt | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K |
| Total Liabilities | 144.97K | 143.50K | 140.04K | 133.99K | 125.00K | 125.00K |
| Stockholders Equity | 142.66M | 148.41M | 114.89M | 101.24M | 102.29M | 105.27M |
Cash Flow | ||||||
| Free Cash Flow | 5.03M | 5.03M | 5.03M | 5.91M | 5.03M | 11.42M |
| Operating Cash Flow | 5.03M | 5.03M | 5.03M | 5.91M | 5.03M | 11.42M |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -5.03M | -5.03M | -5.03M | -5.91M | -5.03M | -11.42M |
Marwyn Value Investors Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MVR2, the sentiment is Negative. The current price of 100.00 is equal to the 20-day moving average (MA) of 100.00, equal to the 50-day MA of 100.00, and below the 200-day MA of 103.47, indicating a neutral trend. The MACD of -0.05 indicates Negative momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 4.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:MVR2.
Marwyn Value Investors Ltd Peers Comparison
Overall Rating
GB:CLIG77Outperform
GB:FSG75Outperform
GB:MVR275Outperform
GB:VLE64Neutral
GB:MERC61Neutral
GB:SBO46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | GBP 214.94M | 11.89 | 15.69% | 5.01% | 5.81% | 19.19% | |
| 75Outperform | GBP 519.70M | 12.41 | 46.72% | 5.75% | 7.26% | 30.92% | |
| 75Outperform | GBP 360.48K | 3.92 | 14.17% | ― | -0.03% | 106.45% | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 64Neutral | GBP 48.40M | 17.18 | 6.56% | ― | 0.98% | -32.75% | |
| 61Neutral | GBP 127.84M | -15.02 | -4.78% | 3.28% | -2.25% | -350.00% | |
| 46Neutral | GBP 46.00M | -18.86 | -3.04% | ― | -193.59% | -773.47% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:MVR2 | Marwyn Value Investors Ltd | 100.00 | -5.00 | -4.76% | |
| GB:CLIG | City of London Investment | 444.00 | 97.74 | 28.23% | |
| GB:MERC | Mercia Asset Management Plc | 30.50 | 1.53 | 5.28% | |
| GB:VLE | Volvere plc | 2250.00 | -260.00 | -10.36% | |
| GB:SBO | Schroder British Opportunities Trust Plc | 62.25 | -12.75 | -17.00% | |
| GB:FSG | Foresight Group Holdings Ltd. | 471.50 | 36.97 | 8.51% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 02, 2026